Intelligent Bio Solutions Inc. (INBS) financial statements and ratios from SEC XBRL: revenue $4.22M (TTM), net margin -294.9%, revenue growth 38.1% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4.22M |
| Net Margin | -294.9% |
| Return on Equity | -235.0% |
| Debt / Equity | 0.31 |
| Current Ratio | 1.44 |
| Revenue Growth (YoY) | 38.1% |
| EPS Growth (YoY) | 322.0% |
| FCF Growth (YoY) | 21.6% |
| Price / Book | 1.54 |
| Price / Sales | 2.05 |
| FCF Yield | -200.7% |
| Altman Z-Score | -10.97 (distress) |
| Sector P/E (Healthcare) | 21.6 |
INBS overview · INBS earnings · INBS KPIs · INBS investor relations · INBS ownership · INBS peers · INBS filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.